Table of Contents
1. Market Overview
1.1 Product Overview and Scope of Market
1.2 Global Market of Cancer Diagnostic Devices
2. Market Insights by Product Type
2.1 Market Revenue by Product Types:
2.1.1 Table Market Revenue (in million USD) by Product Types (Historic Data)
2.1.2 Graph Market Revenue ( in million USD) by Product Types (Current & Forecast Data)
2.1.3 Graph Market Share (%) by Product Types in 2018
2.2 Market Volume by Product Types:
2.2.1 Table Market Volume (in million Units) by Product Types (Historic Data)
2.2.2 Graph Market Volume ( in million Units) by Product Types (Current & Forecast Data)
2.2.3 Graph Market Share (%) by Product Types in 2018
2.3 Genomics Market Analysis
2.3.1 Graph Global Genomics Market Revenue (in million USD ) (2018-26)
2.3.2 Graph Global Genomics Market Volume (in million units ) (2018-26)
2.3.3 Table Genomics Market Geographical Analysis
2.4 Proteomics Market Analysis
2.4.1 Graph Proteomics Market Revenue (in million USD) (2018-26)
2.4.2 Graph Global Proteomics Market Volume (in million Units ) (2018-26)
2.4.3 Table Proteomics Market Geographical Analysis
2.5 Metabolomics
2.6 Epigenetics
3. Market Segment by Applications
• Diagnostic
• Personalized Medicine
• Research
3.1 Table Market Revenue (in million USD) by Application (Historic Data)
3.2 Table Market Revenue (in million USD) by Application (Current & Forecast Data)
3.3 Diagnostic application/ end user analysis
3.3.1 Graph Global Diagnostic Revenue (in million USD ) (2018-26)
3.3.2 Table Global Diagnostic Geographical Analysis
3.4 Personalized Medicine
3.4.1 Graph Global Personalized Medicine Revenue (in million USD ) (2018-26)
3.4.2 Table Global Personalized Medicine Geographical Analysis
4. Regional Market Analysis
4.1.1 Global Market Revenue (In Million) and Growth Rate Comparison by Regions (2018-2026)
4.1. North America Cancer Diagnostic Devices Market Analysis(2018-26)
4.1.1 USA
4.1.2 Canada
4.1.3 Mexico
4.2 Europe Cancer Diagnostic Devices Market Revenue Forecast (2018-27)
4.2.1 UK
4.2.2 Germany
4.2.3 France
4.2.4 Italy
4.2.5 Rest Of Europe
4.3 APAC Cancer Diagnostic Devices Market Revenue Forecast (2018- 2026)
4.3.1 China
4.3.2 Japan
4.3.3 India
4.3.4 Singapore
4.3.5 Malaysia
4.3.6 Rest Of APAC
4.4 Rest Of the World (ROW) Market Revenue Forecast (2018-2026)
4.4.1 Africa
4.4.2 Middle East
4.4.3 South America
5. Competitive Analysis
5.1 Agilent Technologies, Inc. (U.S.)
5.1.1 Overview :
5.1.2 Basic Company Information:
5.1.3 Financial Overview
5.1.3 Production Overview
5.1.4 Geography Revenue Mix ( 2018)
5.1.5Business Revenue Mix
5.1.6 Recent Development
5.2 Thermo Fisher Scientific, Inc. (U.S.)
5.2.1 Overview :
5.2.2 Basic Company Information:
5.2.3 Financial Overview
5.2.4 Production Overview
5.2.5 Geography Revenue Mix ( 2018)
5.2.6 Business Revenue Mix
5.2.7 Recent Development
• Illumina, Inc. (Denmark)
• Becton, Dickinson and Company (U.S.)
• GE Healthcare (U.K.)
• QIAGEN N.V. (Netherlands)
• Abbott Laboratories, Inc. (U.S.)
• Roche Diagnostics (Switzerland)
• Siemens Healthcare (Germany)
• Philips Healthcare (U.K.)
• C.R. Bard, Inc. (U.S.)
6. Research Findings and Conclusion
6.1 Research Finding:
6.2 Conclusion:
7. Methodology and Data Source
7.1 Methodology/Research Approach
7.2 Research Programs/Design
7.3 Market Size Estimation
7.4 Market Breakdown and Data Triangulation
7.5 Data Source
7.5.1 Secondary Sources
7.5.2 Primary Sources
7.6 Disclaimer